Literature DB >> 15708952

Age-related changes of bradykinin B1 and B2 receptors in rat heart.

Ekaterina Kintsurashvili1, Arvi Duka, Ivana Ignjacev, Gregory Pattakos, Irene Gavras, Haralambos Gavras.   

Abstract

Aging is a major risk factor for the development of vascular diseases, such as hypertension and atherosclerosis, that leads to end organ damage and especially heart failure. Bradykinin has been demonstrated to have a cardioprotective role by affecting metabolic processes and tissue perfusion under conditions of myocardial ischemia. Its actions are exerted via the bradykinin B1- and B2-type receptors (B1Rs and B2Rs), but the functional status of these receptors during the aging process is poorly understood. This study aims to investigate whether changes in B1R and B2R gene and protein expression in rat heart are associated with the age-related alterations of cardiac structure and function. Using real-time PCR, we found that B1R mRNA expression increased 2.9-fold in hearts of older rats (24 mo of age) compared with younger rats (3 mo of age), whereas B2R gene expression remained unchanged. Western blot analysis showed that expression of B2R at the protein level is approximately twofold higher in young rats compared with old rats, whereas the B1R protein is approximately twofold higher in old rats compared with young rats. The present results provide clear functional and molecular evidence that indicate age-related changes of bradykinin B1Rs and B2Rs in heart. Because the cardioprotective actions of bradykinin are physiologically mediated via the B2Rs, whereas the B1Rs become induced by tissue damage, these results suggest that age-related decreases in B2R protein levels may leave the heart vulnerable to ischemic damage, and increases in B1R expression and activity may represent a compensatory reaction in aging hearts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708952     DOI: 10.1152/ajpheart.01287.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  11 in total

1.  Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells.

Authors:  Sinisa Stanisavljevic; Tatjana Ignjatovic; Peter A Deddish; Viktor Brovkovych; Kai Zhang; Ervin G Erdös; Randal A Skidgel
Journal:  J Pharmacol Exp Ther       Date:  2005-11-10       Impact factor: 4.030

2.  A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age ≥ 65 years.

Authors:  Yan Zhang; Gregg C Fonarow; Paul W Sanders; Firoozeh Farahmand; Richard M Allman; Inmaculada B Aban; Thomas E Love; Raynald Levesque; Meredith L Kilgore; Ali Ahmed
Journal:  Am J Cardiol       Date:  2011-09-03       Impact factor: 2.778

3.  Early Increased Bradykinin 1 Receptor Contributes to Hemorrhagic Transformation After Ischemic Stroke in Type 1 Diabetic Rats.

Authors:  Hongfei Sang; Zhongming Qiu; Jin Cai; Wenya Lan; Linjie Yu; Hao Zhang; Min Li; Yi Xie; Ruibing Guo; Ruidong Ye; Xinfeng Liu; Ling Liu; Renliang Zhang
Journal:  Transl Stroke Res       Date:  2017-07-19       Impact factor: 6.829

4.  Hereditary Angioedema with and Without C1-Inhibitor Deficiency in Postmenopausal Women.

Authors:  Aurore Billebeau; Olivier Fain; David Launay; Isabelle Boccon-Gibod; Laurence Bouillet; Delphine Gobert; Geneviève Plu-Bureau; Anne Gompel
Journal:  J Clin Immunol       Date:  2020-10-31       Impact factor: 8.317

5.  Bradykinin type-2 receptor expression correlates with age and is subjected to transcriptional regulation.

Authors:  Inka Liesmaa; Naotaka Shiota; Jorma O Kokkonen; Petri T Kovanen; Ken A Lindstedt
Journal:  Int J Vasc Med       Date:  2011-10-03

6.  Bradykinin inhibits oxidative stress-induced cardiomyocytes senescence via regulating redox state.

Authors:  Ruolan Dong; Xizhen Xu; Geng Li; Wenjing Feng; Gang Zhao; Junjie Zhao; Dao Wen Wang; Ling Tu
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

7.  Bradykinin regulates cell growth and migration in cultured human cardiac c-Kit+ progenitor cells.

Authors:  Gang Li; Yan Wang; Gui-Rong Li
Journal:  Oncotarget       Date:  2017-02-14

8.  Expression of B2 Receptor on Circulating CD34-Positive Cells and Outcomes of Myocardial Infarction.

Authors:  Cong Fu; Yuhan Cao; Yuyu Yao; Shengxing Tang; Qun Fan; Yang Ling
Journal:  Dis Markers       Date:  2019-07-08       Impact factor: 3.434

9.  Bradykinin inhibits oxidative stress-induced senescence of endothelial progenitor cells through the B2R/AKT/RB and B2R/EGFR/RB signal pathways.

Authors:  Cong Fu; Bing Li; Yuning Sun; Genshan Ma; Yuyu Yao
Journal:  Oncotarget       Date:  2015-09-22

10.  The natural course of hereditary angioedema in a Chinese cohort.

Authors:  Yang Cao; Shuang Liu; Yuxiang Zhi
Journal:  Orphanet J Rare Dis       Date:  2020-09-22       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.